1. Academic Validation
  2. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice

Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice

  • Eur J Pharmacol. 2000 Oct 6;406(1):149-52. doi: 10.1016/s0014-2999(00)00637-3.
T Andoh 1 Y Kuraishi
Affiliations

Affiliation

  • 1 Department of Applied Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, 930-0194, Toyama, Japan.
Abstract

The anti-pruritic activity of emedastine difumarate was studied in mice. Emedastine (0.03-0.3 mg/kg) inhibited scratching induced by intradermal injection of histamine (100 nmol/site). Scratching induced by substance P (100 nmol/site) and leukotriene B(4) (0.03 nmol/site), but not by serotonin (100 nmol/site), was also suppressed by emedastine (0.03-0.3 mg/kg). Intradermal injection of substance P increased the cutaneous concentration of leukotriene B(4), which was not affected by emedastine. These results suggest that the inhibition by emedastine of substance P-induced itch-associated response is mediated by the blockade of leukotriene B(4) action. Anti-leukotriene B(4) action, as well as the anti-histamine action, may contribute to the anti-pruritic effects of emedastine.

Figures
Products